Category: Markets
Published: 2026-07-02T08:56:41.000Z
China's CSPC Pharmaceutical Group is set to partner with AstraZeneca on a renal disease drug. This collaboration marks another strategic alliance for AstraZeneca in the pharmaceutical sector, following recent partnerships for non-small cell lung cancer treatments. The full details of this specific agreement are reserved for members of the platform.
News summary curated and translated by CausifyMarket. Always consult original sources before making any financial decision.